TY - JOUR
T1 - Long-term outcomes of dialysis patients after coronary revascularization
T2 - A population-based cohort study in Taiwan
AU - Chou, Chu lin
AU - Hsieh, Tsung cheng
AU - Wang, Chih hsien
AU - Hung, Tsung hsing
AU - Lai, Yu hsien
AU - Chen, Yi ya
AU - Lin, Yu li
AU - Kuo, Chiu huang
AU - Wu, Ya ju
AU - Fang, Te chao
PY - 2014/2
Y1 - 2014/2
N2 - Background and Aims: The outcomes of Chinese patients undergoing dialysis after coronary revascularization are unknown. We examined the outcomes of Taiwanese dialysis patients after coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), or coronary stenting. Methods: Using data from the National Health Research Institute database, we determined the outcomes of 1,287 dialysis patients who underwent initial coronary revascularization between 1997 and2008. Results: The 7-year overall survival rates were 69 ± 4%, 68 ± 3%, and 57 ± 2% for the CABG, stent, and PTCA patients (p= 0.001), respectively. After demographic and comorbidity adjustment, hazard ratios (HRs) for all-cause death in the CABG (vs. PTCA) and stent (vs. PTCA) patients were 0.695 (p= 0.015) and 0.721 (p= 0.009). Additionally, no significant difference in all-cause death was found between the CABG and stent patients. Moreover, the ≥65-year-old CABG group patients and the
AB - Background and Aims: The outcomes of Chinese patients undergoing dialysis after coronary revascularization are unknown. We examined the outcomes of Taiwanese dialysis patients after coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), or coronary stenting. Methods: Using data from the National Health Research Institute database, we determined the outcomes of 1,287 dialysis patients who underwent initial coronary revascularization between 1997 and2008. Results: The 7-year overall survival rates were 69 ± 4%, 68 ± 3%, and 57 ± 2% for the CABG, stent, and PTCA patients (p= 0.001), respectively. After demographic and comorbidity adjustment, hazard ratios (HRs) for all-cause death in the CABG (vs. PTCA) and stent (vs. PTCA) patients were 0.695 (p= 0.015) and 0.721 (p= 0.009). Additionally, no significant difference in all-cause death was found between the CABG and stent patients. Moreover, the ≥65-year-old CABG group patients and the
KW - Coronary artery bypass grafting
KW - Dialysis
KW - Percutaneous transluminal coronary angioplasty
KW - Stent
UR - http://www.scopus.com/inward/record.url?scp=84896808646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896808646&partnerID=8YFLogxK
U2 - 10.1016/j.arcmed.2014.01.009
DO - 10.1016/j.arcmed.2014.01.009
M3 - Article
C2 - 24512923
AN - SCOPUS:84896808646
SN - 0188-4409
VL - 45
SP - 188
EP - 194
JO - Archives of Medical Research
JF - Archives of Medical Research
IS - 2
ER -